Results 71 to 80 of about 20,522 (204)
Atherosclerosis: From Pathogenesis to Therapeutic Interventions
The diagram outlines the core mechanisms driving atherosclerosis, including endothelial dysfunction, inflammatory responses, phenotypic switching of smooth muscle cells, and the gut–vascular axis. It also presents the corresponding therapeutic approaches now under development, such as gene therapies, immunotherapies, and nanotechnology platforms ...
Enge Zhou +9 more
wiley +1 more source
The effects of ezetimibe on omega-3 fatty acid absorption in the prevention of cardiovascular disease [PDF]
Omega-3 polyunsaturated fatty acids like alpha-linolenic acid (ALA) may be beneficial for cardiovascular health. A cholesterol supplemented diet will increase ALA bioavailability. Conversely, drugs which inhibit intestinal cholesterol metabolism may also
Blackwood, David Palmer
core
Simultaneous Spectrophotometric Determination of Valsartan and Ezetimibe in Pharmaceuticals [PDF]
Purpose: To develop a direct, simple and extraction-free spectrophotometric method for the simultaneous estimation of valsartan and ezetimibe in pharmaceuticals.Methods: A spectrophotometric method for the determination of valsartan and ezetimibe was ...
Mandal, BK +2 more
core +1 more source
STUDYING MOLECULAR MODELLING OF THE CHOLESTEROL ABSORPTION INHIBITOR EZETIMIBE AND EVALUATION OF ITS ANTIBACTERIAL ACTIVITY [PDF]
As is known, ezetimibe is the only drug classified as a cholesterol absorption inhibitor, working by preventing the cholesterol transporter protein Niemann-Pick C1-Like 1 (NPC1L1) from functioning.
Manila Mohammed +4 more
doaj +1 more source
Vitamin D: Physiology, Pharmacology and Clinical Evidence for Supplementation—A Narrative Review
ABSTRACT Vitamin D is a nutrient and prohormone obtained from diet and supplements and synthesized in the skin. It is essential for calcium and phosphate homeostasis and skeletal health and influences multiple extra‐skeletal processes, yet deficiency remains common worldwide.
Jyrki K. Virtanen
wiley +1 more source
Sahar Naderi,1 JoAnne M Foody21Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USAAbstract: The majority of chronic kidney disease ...
Foody JM, Naderi S
core
Effect of ezetimibe on cholesterol transit in mice.
A, An illustrated protocol for the 3H-cholesterol distribution assay. B, Upper; 3H-decay per minute (DPM) count distribution 3 h after 3H-cholesterol was given orally to C57BL/6J mice.
Hiraku Ono (3214602) +6 more
core +1 more source
Recent clinical research has shown that atorvastatin in combination with cholesterol absorption inhibitor ezetimibe significantly reduces LDL-C level in patients with hypercholesterolemia, showing a superior lipid-lowering efficacy compared to statin ...
Omar ePatiño-Rodríguez +4 more
doaj +1 more source
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert +12 more
wiley +1 more source
ABSTRACT Aims The association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and the development of bowel obstruction/ileus remains unclear, and evidence for specific bowel obstruction/ileus subtypes remains limited. We examined the association between GLP‐1RA use and the incidence of bowel obstruction/ileus subtypes across different ...
Yuichiro Matsuo +3 more
wiley +1 more source

